Skip to main content
. Author manuscript; available in PMC: 2021 Aug 6.
Published in final edited form as: Epidemiology. 2020 Jul;31(4):570–577. doi: 10.1097/EDE.0000000000001201

Figure 1.

Figure 1.

Risk of antiretroviral therapy initiation over 2 years since entry into care among 19,506 patients who entered HIV care at one of 15 Central Africa IeDEA sites between 1 January 2006 and 31 December 2017 after censoring patients lost to follow-up (LTFU; light grey curves), treating loss to follow-up as a competing event (dark grey curves), and accounting for loss to follow-up using the proposed approach (black curves)